Sponsor Pipeline

Shambavi Richard Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-27 NCT07727668 Iberdomide (CC-220) Priming to Improve T Cell Fitness Prior to Leukapheresis for Chimeric… Early Phase 1 Not Yet Recruiting
Active Trials by Phase
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Early Phase 1
NCT07727668 Iberdomide (CC-220) Priming to Improve T Cell Fitness Prior to Leukapheresis for Chimeric… Multiple Myeloma Not Yet Recruiting
Disease Areas
Multiple Myeloma (1)
Get alerts when Shambavi Richard's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free